Nishadil
Signup Signin
Delhi | 25°C (windy)
The Revolving Door: Ex-FDA Regulators Find New Homes at Pharma Giants Like Eli Lilly

The Revolving Door: Ex-FDA Regulators Find New Homes at Pharma Giants Like Eli Lilly
The High-Stakes Battle Over Elevidys: Efficacy, Ethics, and the Future of Rare Disease Drugs

The High-Stakes Battle Over Elevidys: Efficacy, Ethics, and the Future of Rare Disease Drugs
The Pharmaceutical Tsunami: How a Second Trump Term Could Reshape Drug Pricing, Medicare, and Vaccines

The Pharmaceutical Tsunami: How a Second Trump Term Could Reshape Drug Pricing, Medicare, and Vaccines
STAT+: Sen. Sanders, others lawmakers open probe into asthma inhaler makers over pricing, patent maneuvers

STAT+: Sen. Sanders, others lawmakers open probe into asthma inhaler makers over pricing, patent maneuvers
STAT+: FDA is blasted by advocates for pursuing a deal with data provider that has ties to opioid makers

STAT+: FDA is blasted by advocates for pursuing a deal with data provider that has ties to opioid makers
Load more..